Bringing the endovascular neurosurgeon into the neuro-oncology treatment team

World Neurosurgery

Volumn 77, Issue 1, 2012, Pages 59-61

  Peruzzi, Pierpaolo ^a   Chiocca, E Antonio ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Bevacizumab; Glioblastoma; Intra arterial chemotherapy; Overall survival; Progression free survival

Indexed keywords

BEVACIZUMAB; GADOLINIUM; MANNITOL; VASCULOTROPIN;

ANGIOGENESIS; BLEEDING; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; COLORECTAL CANCER; DISEASE COURSE; FEASIBILITY STUDY; FOLLOW UP; GLIOBLASTOMA; HUMAN; HYPERTENSION; KIDNEY CANCER; LUNG CANCER; NEUROECTODERM TUMOR; NEUROSURGEON; NEUROSURGERY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL (TOPIC); PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGRESSION FREE SURVIVAL; RASH; RECURRENT CANCER; RECURRENT DISEASE; REVIEW; SEIZURE; SEPSIS; THROMBOEMBOLISM; WOUND DEHISCENCE;

EID: 84858036332     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2011.07.038     Document Type: Article

References (20)

1. M.S. Ahluwalia, C.L. Gladson Progress on antiangiogenic therapy for patients with malignant glioma J Oncol 2010 2010 689018
2. S. Bao, Q. Wu, S. Sathornsumetee, Y. Hao, Z. Li, A.B. Hjelmeland, Q. Shi, R.E. McLendon, D.D. Bigner, J.N. Rich Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor Cancer Res 66 2006 7843 7848 (Pubitemid 44299144)
3. J.A. Boockvar, A.J. Tsiouris, C.P. Hofstetter, I. Kovanlikaya, S. Fralin, K. Kesavabhotla, S.M. Seedial, S.C. Pannullo, T.H. Schwartz, P. Stieg, R.D. Zimmerman, J. Knopman, R.J. Scheff, P. Christos, S. Vallabhajosula, H.A. Riina Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma J Neurosurg 114 2011 624 632
4. N.D. Doolittle, M.E. Miner, W.A. Hall, T. Siegal, E. Jerome, E. Osztie, L.D. McAllister, J.S. Bubalo, D.F. Kraemer, D. Fortin, R. Nixon, L.L. Muldoon, E.A. Neuwelt Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors Cancer 88 2000 637 647 (Pubitemid 30056941)
5. D. Fortin, C. Gendron, M. Boudrias, M.P. Garant Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis Cancer 109 2007 751 760 (Pubitemid 46233237)
6. H.S. Friedman, M.D. Prados, P.Y. Wen, T. Mikkelsen, D. Schiff, L.E. Abrey, W.K. Yung, N. Paleologos, M.K. Nicholas, R. Jensen, J. Vredenburgh, J. Huang, M. Zheng, T. Cloughesy Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma J Clin Oncol 27 2009 4733 4740
7. E.R. Gerstner, M.P. Frosch, T.T. Batchelor Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab J Clin Oncol 28 2010 e91 e93
8. L.C. Hou, A. Veeravagu, A.R. Hsu, V.C. Tse Recurrent glioblastoma multiforme: a review of natural history and management options Neurosurg Focus 20 2006 E5
9. H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, A. Baron, S. Griffing, E. Holmgren, N. Ferrara, G. Fyfe, B. Rogers, R. Ross, F. Kabbinavar Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342 (Pubitemid 38702844)
10. F. Imbesi, E. Marchioni, E. Benericetti, F. Zappoli, A. Galli, M. Corato, M. Ceroni A randomized phase III study: comparison between intravenous and intraarterial ACNU administration in newly diagnosed primary glioblastomas Anticancer Res 26 2006 553 558 (Pubitemid 43206015)
11. K. Jahnke, D.F. Kraemer, K.R. Knight, D. Fortin, S. Bell, N.D. Doolittle, L.L. Muldoon, E.A. Neuwelt Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system Cancer 112 2008 581 588 (Pubitemid 351186198)
12. D.H. Johnson, L. Fehrenbacher, W.F. Novotny, R.S. Herbst, J.J. Nemunaitis, D.M. Jablons, C.J. Langer, R.F. DeVore 3rd, J. Gaudreault, L.A. Damico, E. Holmgren, F. Kabbinavar Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic nonsmall-cell lung cancer J Clin Oncol 22 2004 2184 2191 (Pubitemid 41095154)
13. M. Kochii, I. Kitamura, T. Goto, T. Nishi, H. Takeshima, Y. Saito, K. Yamamoto, T. Kimura, T. Kino, K. Tada, S. Shiraishi, S. Uemura, T. Iwasaki, J. Kuratsu, Y. Ushio Randomized comparison of intra-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma J Neurooncol 49 2000 63 70
14. National Cancer Institute National Institutes of Health Cancer drug information http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab
15. E.A. Neuwelt, D.L. Goldman, S.A. Dahlborg, J. Crossen, F. Ramsey, S. Roman-Goldstein, R. Braziel, B. Dana Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function J Clin Oncol 9 1991 1580 1590
16. H.A. Riina, J.F. Fraser, S. Fralin, J. Knopman, R.J. Scheff, J.A. Boockvar Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma J Exp Ther Oncol 8 2009 145 150
17. M.O. Stefanini, F.T.H. Wu, F. Mac Gabhann, A.S. Popel The presence of VEGF Receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling PLoS Comput Biol 5 2009 e1000622
18. C.H. Wang, J.K. Rockhill, M. Mrugala, D.L. Peacock, A. Lai, K. Jusenius, J.M. Wardlaw, T. Cloughesy, A.M. Spence, R. Rockne, E.C. Alvord Jr, K.R. Swanson Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model Cancer Res 69 2009 9133 9140
19. P.Y. Wen, D.R. Macdonald, D.A. Reardon, T.F. Cloughesy, A.G. Sorensen, E. Galanis, J. Degroot, W. Wick, M.R. Gilbert, A.B. Lassman, C. Tsien, T. Mikkelsen, E.T. Wong, M.C. Chamberlain, R. Stupp, K.R. Lamborn, M.A. Vogelbaum, M.J. van den Bent, S.M. Chang Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 2010 1963 1972
20. J.C. Yang, L. Haworth, R.M. Sherry, P. Hwu, D.J. Schwartzentruber, S.L. Topalian, S.M. Steinberg, H.X. Chen, S.A. Rosenberg A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer N Engl J Med 349 2003 427 434 (Pubitemid 36910021)